- Home
- NECB vs AMRN Comparison
NECB vs AMRN Comparison
Compare NECB & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NECB | AMRN |
|---|---|---|
| Founded | 1934 | 1989 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 329.2M | 304.6M |
| IPO Year | 2021 | 1998 |
Fundamental Metrics
Financial Performance| Metric | NECB | AMRN |
|---|---|---|
| Price | $24.56 | $14.49 |
| Analyst Decision | Strong Buy | Strong Sell |
| Analyst Count | 1 | 1 |
| Target Price | ★ $30.00 | $12.00 |
| AVG Volume (30 Days) | 31.3K | ★ 35.9K |
| Earning Date | 04-24-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.00% | N/A |
| EPS Growth | N/A | ★ 55.00 |
| EPS | ★ 3.25 | N/A |
| Revenue | N/A | ★ $181,104,000.00 |
| Revenue This Year | $4.85 | N/A |
| Revenue Next Year | $8.45 | $1.26 |
| P/E Ratio | $7.70 | ★ N/A |
| Revenue Growth | N/A | ★ 39.22 |
| 52 Week Low | $19.27 | $8.84 |
| 52 Week High | $25.65 | $20.90 |
Technical Indicators
Market Signals| Indicator | NECB | AMRN |
|---|---|---|
| Relative Strength Index (RSI) | 62.33 | 44.69 |
| Support Level | $22.34 | $14.39 |
| Resistance Level | N/A | $14.74 |
| Average True Range (ATR) | 0.54 | 0.51 |
| MACD | 0.12 | -0.01 |
| Stochastic Oscillator | 79.15 | 52.43 |
Price Performance
Historical ComparisonAbout NECB NorthEast Community Bancorp Inc.
NorthEast Community Bancorp Inc operates as a community-oriented financial institution. It is principally engaged in the business of attracting deposits and investing those funds into mortgage and commercial loans. It conducts activities throughout the Northeastern United States, including New York, Massachusetts, New Jersey, and Connecticut. The company offers a comprehensive line of banking products and services, including mobile banking as well as commercial real estate loans, commercial construction financing, lines of credit, and term loans. It also offers investment advisory and financial planning services.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.